Recent Company News

• 06:25 AM ET Jun 25, 2025
  

  Autos, tech, defense stronger; media, telecom and real estate main aggards:

• 04:04 AM ET May 06, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:55 AM ET Jun 25, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:31 AM ET Jun 25, 2025
  

  Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular understanding of acute kidney injury (€6.88, 0.00)

• 07:44 AM ET Jun 12, 2025
  

  StreetAccount Summary - European unusual volume traders

• 09:00 PM ET May 23, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 09:02 AM ET May 23, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 05:51 PM ET May 07, 2025
  

  FDA grants orphan drug designation to Sema3A for Alport syndrome (€23.44, 0.00)

• 01:37 AM ET May 07, 2025
  

  Evotec awarded $2.5M grant by the Gates Foundation to generate next generation tuberculosis treatments (€7.29, 0.00)